Hana Biosciences, Inc. (NASDAQ: HNAB), a South San Francisco, CA-based biopharmaceutical company, is focused on the acquisition, development and commercialization of novel products to strengthen the foundation of cancer care. The company is dedicated to creating value by accelerating the development of lead product candidates, building a best-in-class team, expanding its pipeline, and nurturing a unique company culture. For further information, visit the Company’s web site at www.hanabiosciences.com.
- 17 years ago
QualityStocks
Hana Biosciences, Inc. (NASDAQ: HNAB)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Perpetuals.com Ltd. (NASDAQ: PDC) CEO To Present At Emerging Growth Conference
Perpetuals.com (NASDAQ: PDC) announced that CEO Patrick Gruhn will present and host a live question-and-answer session…
-
QualityStocksNewsBreaks – Pelican Acquisition Corp. (NASDAQ: PELI) Approves Business Combination With Greenland Exploration And Pelican Holdco
Pelican Acquisition (NASDAQ: PELI) announced that shareholders approved its proposed business combination with Pelican Holdco…
-
QualityStocksNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Signs Strategic Cooperation Agreement With BonV Aero To Expand Counter-UAS Presence In India
ParaZero Technologies (NASDAQ: PRZO) announced the signing of a strategic cooperation agreement with India-based BonV…